Literature DB >> 20391433

Blood-stage Plasmodium berghei infection leads to short-lived parasite-associated antigen presentation by dendritic cells.

Rachel J Lundie1, Louise J Young, Gayle M Davey, Jose A Villadangos, Francis R Carbone, William R Heath, Brendan S Crabb.   

Abstract

Despite extensive evidence that Plasmodium species are capable of stimulating the immune system, the association of malaria with a higher incidence of other infectious diseases and reduced responses to vaccination against unrelated pathogens suggests the existence of immune suppression. Recently, we provided evidence that blood-stage Plasmodium berghei infection leads to suppression of MHC class I-restricted immunity to third party (non-malarial) antigens as a consequence of systemic DC activation. This earlier study did not, however, determine whether reactivity was also impaired to MHC class II-restricted third party antigens or to Plasmodium antigens themselves. Here, we show that while P. berghei-expressed antigens were presented early in infection, there was a rapid decline in presentation within 4 days, paralleling impairment in MHC class I- and II-restricted presentation of third party antigens. This provides important evidence that P. berghei not only causes immunosuppression to subsequently encountered third party antigens, but also rapidly limits the capacity to generate effective parasite-specific immunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20391433     DOI: 10.1002/eji.200939265

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  23 in total

1.  Development of a Novel CD4+ TCR Transgenic Line That Reveals a Dominant Role for CD8+ Dendritic Cells and CD40 Signaling in the Generation of Helper and CTL Responses to Blood-Stage Malaria.

Authors:  Daniel Fernandez-Ruiz; Lei Shong Lau; Nazanin Ghazanfari; Claerwen M Jones; Wei Yi Ng; Gayle M Davey; Dorothee Berthold; Lauren Holz; Yu Kato; Matthias H Enders; Ganchimeg Bayarsaikhan; Sanne H Hendriks; Lianne I M Lansink; Jessica A Engel; Megan S F Soon; Kylie R James; Anton Cozijnsen; Vanessa Mollard; Alessandro D Uboldi; Christopher J Tonkin; Tania F de Koning-Ward; Paul R Gilson; Tsuneyasu Kaisho; Ashraful Haque; Brendan S Crabb; Francis R Carbone; Geoffrey I McFadden; William R Heath
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

2.  Type I IFN signaling in CD8- DCs impairs Th1-dependent malaria immunity.

Authors:  Ashraful Haque; Shannon E Best; Marcela Montes de Oca; Kylie R James; Anne Ammerdorffer; Chelsea L Edwards; Fabian de Labastida Rivera; Fiona H Amante; Patrick T Bunn; Meru Sheel; Ismail Sebina; Motoko Koyama; Antiopi Varelias; Paul J Hertzog; Ulrich Kalinke; Sin Yee Gun; Laurent Rénia; Christiane Ruedl; Kelli P A MacDonald; Geoffrey R Hill; Christian R Engwerda
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

3.  Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.

Authors:  Takahiko Tamura; Kazumi Kimura; Masao Yuda; Katsuyuki Yui
Journal:  Infect Immun       Date:  2011-08-01       Impact factor: 3.441

Review 4.  Pathogenic CD8+ T cells in experimental cerebral malaria.

Authors:  Shanshan Wu Howland; Carla Claser; Chek Meng Poh; Sin Yee Gun; Laurent Rénia
Journal:  Semin Immunopathol       Date:  2015-03-13       Impact factor: 9.623

5.  Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection.

Authors:  Pierre Guermonprez; Julie Helft; Carla Claser; Stephanie Deroubaix; Henry Karanje; Anna Gazumyan; Guillaume Darasse-Jèze; Stephanie B Telerman; Gaëlle Breton; Heidi A Schreiber; Natalia Frias-Staheli; Eva Billerbeck; Marcus Dorner; Charles M Rice; Alexander Ploss; Florian Klein; Melissa Swiecki; Marco Colonna; Alice O Kamphorst; Matthew Meredith; Rachel Niec; Constantin Takacs; Fadi Mikhail; Aswin Hari; David Bosque; Tom Eisenreich; Miriam Merad; Yan Shi; Florent Ginhoux; Laurent Rénia; Britta C Urban; Michel C Nussenzweig
Journal:  Nat Med       Date:  2013-05-19       Impact factor: 53.440

6.  Transient deficiency of dendritic cells results in lack of a merozoite surface protein 1-specific CD4 T cell response during peak Plasmodium chabaudi blood-stage infection.

Authors:  Anne-Marit Sponaas; Nikolai Belyaev; Mika Falck-Hansen; Alexandre Potocnik; Jean Langhorne
Journal:  Infect Immun       Date:  2012-09-24       Impact factor: 3.441

Review 7.  Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions?

Authors:  Noah S Butler; Tajie H Harris; Ira J Blader
Journal:  Trends Parasitol       Date:  2013-11-01

8.  The subcellular location of ovalbumin in Plasmodium berghei blood stages influences the magnitude of T-cell responses.

Authors:  Jing-Wen Lin; Tovah N Shaw; Takeshi Annoura; Aurélie Fougère; Pascale Bouchier; Séverine Chevalley-Maurel; Hans Kroeze; Blandine Franke-Fayard; Chris J Janse; Kevin N Couper; Shahid M Khan
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

9.  Plasmodium falciparum-derived uric acid precipitates induce maturation of dendritic cells.

Authors:  Diana L van de Hoef; Isabelle Coppens; Thomas Holowka; Choukri Ben Mamoun; OraLee Branch; Ana Rodriguez
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

10.  The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessment.

Authors:  Anna L Goodman; Emily K Forbes; Andrew R Williams; Alexander D Douglas; Simone C de Cassan; Karolis Bauza; Sumi Biswas; Matthew D J Dicks; David Llewellyn; Anne C Moore; Chris J Janse; Blandine M Franke-Fayard; Sarah C Gilbert; Adrian V S Hill; Richard J Pleass; Simon J Draper
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.